OpenAI acquires Orchestra Bio

October 20, 2026

OpenAI acquired Orchestra Bio, whose agents help biopharma teams monitor studies, track drug programs and identify delays. Its team and technology joined Rosalind, OpenAI's life-sciences models and tools.

OpenAI Orchestra Bio

Sources

OpenAI

Announcement · Oct 20, 2026

OpenAI acquires Orchestra Bio

Additional sources

Axios

News · Oct 20, 2026

Exclusive: OpenAI acquires biotech startup as AI race moves into drug development

previous event

Meta pauses Muse conversation sharing after a privacy report

next event

Anthropic opens a research preview of Claude Duet